Getinge AB (publ) (GNGBF)
USD 21.11
(4.4%)
USD 21.11
(4.4%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 8.07 Billion SEK | 38.67% |
| 2022 | 5.82 Billion SEK | 35.25% |
| 2021 | 4.3 Billion SEK | -57.81% |
| 2020 | 10.2 Billion SEK | 1.86% |
| 2019 | 10.02 Billion SEK | -7.47% |
| 2018 | 10.82 Billion SEK | -3.63% |
| 2017 | 11.23 Billion SEK | -48.22% |
| 2016 | 21.7 Billion SEK | 1.96% |
| 2015 | 21.28 Billion SEK | 2.56% |
| 2014 | 20.75 Billion SEK | 20.86% |
| 2013 | 17.16 Billion SEK | -2.03% |
| 2012 | 17.52 Billion SEK | 5.01% |
| 2011 | 16.68 Billion SEK | 31.87% |
| 2010 | 12.65 Billion SEK | -21.16% |
| 2009 | 16.05 Billion SEK | 22.07% |
| 2008 | 13.15 Billion SEK | 42.73% |
| 2007 | 9.21 Billion SEK | 108.53% |
| 2006 | 4.41 Billion SEK | 7.52% |
| 2005 | 4.1 Billion SEK | 11.11% |
| 2004 | 3.69 Billion SEK | 13.97% |
| 2003 | 3.24 Billion SEK | 34.36% |
| 2002 | 2.41 Billion SEK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 8.61 Billion SEK | 3.36% |
| 2024 Q3 | 9.13 Billion SEK | 26.21% |
| 2024 Q1 | 8.33 Billion SEK | 3.16% |
| 2023 Q4 | 8.07 Billion SEK | 18.52% |
| 2023 Q1 | 5.81 Billion SEK | -0.14% |
| 2023 Q2 | 6.89 Billion SEK | 18.52% |
| 2023 Q3 | 6.81 Billion SEK | -1.15% |
| 2023 FY | 8.07 Billion SEK | 38.67% |
| 2022 Q4 | 5.82 Billion SEK | 5.91% |
| 2022 Q2 | 5.38 Billion SEK | 25.62% |
| 2022 Q1 | 4.29 Billion SEK | -0.37% |
| 2022 Q3 | 5.49 Billion SEK | 2.04% |
| 2022 FY | 5.82 Billion SEK | 35.25% |
| 2021 Q2 | 5.5 Billion SEK | -31.84% |
| 2021 FY | 4.3 Billion SEK | -57.81% |
| 2021 Q4 | 4.3 Billion SEK | -22.48% |
| 2021 Q3 | 5.55 Billion SEK | 0.85% |
| 2021 Q1 | 8.08 Billion SEK | -20.82% |
| 2020 Q4 | 10.2 Billion SEK | -15.2% |
| 2020 FY | 10.2 Billion SEK | 1.86% |
| 2020 Q1 | 11.11 Billion SEK | 10.9% |
| 2020 Q2 | 13.28 Billion SEK | 19.53% |
| 2020 Q3 | 12.03 Billion SEK | -9.38% |
| 2019 Q3 | 11.63 Billion SEK | -0.54% |
| 2019 Q2 | 11.69 Billion SEK | 0.03% |
| 2019 FY | 10.02 Billion SEK | -7.47% |
| 2019 Q1 | 11.69 Billion SEK | 7.96% |
| 2019 Q4 | 10.02 Billion SEK | -13.86% |
| 2018 Q2 | 11.56 Billion SEK | 5.63% |
| 2018 Q4 | 10.82 Billion SEK | 0.9% |
| 2018 FY | 10.82 Billion SEK | -3.63% |
| 2018 Q3 | 10.73 Billion SEK | -7.18% |
| 2018 Q1 | 10.94 Billion SEK | -2.59% |
| 2017 FY | 11.23 Billion SEK | -48.22% |
| 2017 Q1 | 21.72 Billion SEK | 0.12% |
| 2017 Q3 | 16.14 Billion SEK | -22.73% |
| 2017 Q2 | 20.89 Billion SEK | -3.82% |
| 2017 Q4 | 11.23 Billion SEK | -30.41% |
| 2016 Q4 | 21.7 Billion SEK | -1.04% |
| 2016 FY | 21.7 Billion SEK | 1.96% |
| 2016 Q3 | 21.92 Billion SEK | -0.64% |
| 2016 Q2 | 22.07 Billion SEK | 1.57% |
| 2016 Q1 | 21.73 Billion SEK | 2.1% |
| 2015 Q4 | 21.28 Billion SEK | -2.81% |
| 2015 FY | 21.28 Billion SEK | 2.56% |
| 2015 Q3 | 21.89 Billion SEK | 1.41% |
| 2015 Q2 | 21.59 Billion SEK | -3.07% |
| 2015 Q1 | 22.27 Billion SEK | 7.35% |
| 2014 Q2 | 19.09 Billion SEK | 17.83% |
| 2014 Q3 | 19.99 Billion SEK | 4.73% |
| 2014 Q4 | 20.75 Billion SEK | 3.77% |
| 2014 Q1 | 16.2 Billion SEK | -5.61% |
| 2014 FY | 20.75 Billion SEK | 20.86% |
| 2013 Q2 | 18.63 Billion SEK | 0.0% |
| 2013 Q1 | - SEK | -100.0% |
| 2013 Q4 | 17.16 Billion SEK | 5.82% |
| 2013 FY | 17.16 Billion SEK | -2.03% |
| 2013 Q3 | 16.22 Billion SEK | -12.91% |
| 2012 Q2 | - SEK | 0.0% |
| 2012 Q4 | 17.52 Billion SEK | 0.0% |
| 2012 FY | 17.52 Billion SEK | 5.01% |
| 2012 Q1 | - SEK | -100.0% |
| 2012 Q3 | - SEK | 0.0% |
| 2011 FY | 16.68 Billion SEK | 31.87% |
| 2011 Q4 | 16.68 Billion SEK | 0.0% |
| 2011 Q3 | - SEK | 0.0% |
| 2011 Q2 | - SEK | 0.0% |
| 2011 Q1 | - SEK | -100.0% |
| 2010 Q1 | - SEK | -100.0% |
| 2010 Q2 | - SEK | 0.0% |
| 2010 Q4 | 12.65 Billion SEK | 0.0% |
| 2010 Q3 | - SEK | 0.0% |
| 2010 FY | 12.65 Billion SEK | -21.16% |
| 2009 Q4 | 16.05 Billion SEK | 0.0% |
| 2009 FY | 16.05 Billion SEK | 22.07% |
| 2008 FY | 13.15 Billion SEK | 42.73% |
| 2007 FY | 9.21 Billion SEK | 108.53% |
| 2006 FY | 4.41 Billion SEK | 7.52% |
| 2005 FY | 4.1 Billion SEK | 11.11% |
| 2004 FY | 3.69 Billion SEK | 13.97% |
| 2003 FY | 3.24 Billion SEK | 34.36% |
| 2002 FY | 2.41 Billion SEK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| IR-Med Inc. | 161 Thousand USD | -5016049.068% |
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 14.83 Million USD | -54352.636% |
| Medical Supply International USA, Inc. | 227 Thousand USD | -3557577.906% |
| Polarean Imaging plc | 216.38 Thousand USD | -3732136.523% |
| Avitar, Inc. | 5.26 Million USD | -153283.729% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -1796630.911% |
| Manhattan Scientifics, Inc. | 60 Thousand USD | -13459900.0% |
| Össur hf. | 467.73 Million USD | -1626.626% |
| Zecotek Photonics Inc. | 3.22 Million USD | -250562.816% |
| QHSLab, Inc. | 1.78 Million USD | -453212.617% |
| Wellstar International, Inc. | 51.36 Million USD | -15622.176% |
| Össur hf. | 467.73 Million USD | -1626.626% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 5.21 Million USD | -154671.142% |
| Escalon Medical Corp. | 524.71 Thousand USD | -1539009.504% |
| Aurora Spine Corporation | 2.67 Million USD | -302308.484% |
| BrainsWay Ltd. | 471 Thousand USD | -1714549.682% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 3 Million USD | -269100.0% |
| Hamilton Thorne Ltd. | 27.81 Million USD | -28939.034% |
| Vivos Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 1.69 Billion USD | -375.538% |
| Kelyniam Global, Inc. | 496.39 Thousand USD | -1626817.057% |
| REMSleep Holdings, Inc. | 178.11 Thousand USD | -4534074.742% |
| CYduct Diagnostics, Inc. | 670 Thousand USD | -1205273.134% |
| Nanomix Corporation | 11.4 Million USD | -70703.188% |
| Theraclion SA | 1.95 Million EUR | -413897.589% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 4.04 Million USD | -199702.919% |
| Positron Corporation | 1.78 Million USD | -451695.855% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.69 Million USD | -475365.486% |
| Lombard Medical, Inc. | 32.29 Million USD | -24909.29% |
| ALR Technologies Inc. | 19.26 Million USD | -41822.394% |
| Stratec SE | 156.16 Million USD | -5071.438% |
| Vycor Medical, Inc. | 1.11 Million USD | -727305.048% |
| Heart Tronics, Inc. | 209.28 Thousand USD | -3858752.761% |
| Nu-Med Plus, Inc. | 100 Thousand USD | -8075900.0% |
| Perimeter Medical Imaging AI, Inc. | 192.89 Thousand USD | -4186655.42% |
| SANUWAVE Health, Inc. | 31.94 Million USD | -25181.743% |
| VMS Rehab Systems, Inc. | 133.52 USD | -6048531955.123% |
| Guided Therapeutics, Inc. | 2.05 Million USD | -392320.016% |
| Ingen Technologies, Inc. | 631.15 Thousand USD | -1279454.849% |
| Odyssey Group International, Inc. | 2.14 Million USD | -376463.185% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 3.17 Million USD | -254562.506% |
| Capital Group Holdings, Inc. | 4944.00 USD | -163349414.563% |
| ADM Tronics Unlimited, Inc. | 799.65 Thousand USD | -1009830.483% |
| Urologix, Inc. | 5.33 Million USD | -151334.465% |
| Rapid Therapeutic Science Laboratories, Inc. | 3.83 Million USD | -210724.243% |
| Nexeon MedSystems Inc. | 4.21 Million USD | -191491.923% |
| SS Innovations International, Inc. | 8.21 Million USD | -98167.948% |
| Qualis Innovations, Inc. | 9102.00 USD | -88727652.142% |
| Smith & Nephew plc | 3.07 Billion USD | -162.238% |
| NIOX Group Plc | 1.4 Million USD | -576633.557% |
| Fuse Medical, Inc. | 1.99 Million USD | -404983.71% |
| Broncus Holding Corporation | 2.35 Million USD | -342923.157% |
| Brain Scientific Inc. | 2.86 Million USD | -281933.955% |
| Pressure BioSciences, Inc. | 22.75 Million USD | -35385.85% |
| Health Logic Interactive Inc. | 40.44 Thousand USD | -19969238.806% |